login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
MINERVA NEUROSCIENCES INC (NERV) Stock News
NASDAQ:NERV - Nasdaq -
US6033802058
-
Common Stock
- Currency: USD
1.9501
-0.15 (-7.14%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
NERV Latest News, Press Relases and Analysis
All
Press Releases
3 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
3 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2025 Financial Results and Business Updates
4 months ago - By: Benzinga
- Mentions:
CRIS
GOVX
HCTI
BSGM
...
12 Health Care Stocks Moving In Monday's After-Market Session
5 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
a year ago - By: BusinessInsider
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
a year ago - By: InvestorPlace
NERV Stock Earnings: Minerva Neurosciences Beats EPS for Q1 2024
a year ago - By: Benzinga
Minerva Neurosciences: Q4 Earnings Insights
5 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2024 Financial Results and Business Updates
9 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
9 months ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Third Quarter 2024 Financial Results and Business Updates
a year ago - By: InvestorPlace
NERV Stock Earnings: Minerva Neurosciences Misses EPS for Q2 2024
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
a year ago - By: Seeking Alpha
Minerva stock falls as FDA rejects schizophrenia drug
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
a year ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
2 years ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
2 years ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
2 years ago - By: Minerva Neurosciences, Inc
Minerva Neurosciences Reports 2023 Second Quarter Financial Results and Business Updates
Please enable JavaScript to continue using this application.